Healthcare (SH:603313)2020-10-26 16:00Financial Performance - Operating revenue for the first nine months was RMB 4,526,354,598.57, representing a 71.53% increase compared to the same period last year[9] - Net profit attributable to shareholders was RMB 345,557,937.16, up 32.66% year-over-year[9] - Basic earnings per share were RMB 1.01, an increase of 23.17% from RMB 0.82 in the same period last year[9] - The weighted average return on equity rose to 13.44%, an increase of 0.93 percentage points year-over-year[9] - Total operating revenue for Q3 2020 reached ¥2,110,333,570.59, a significant increase of 99.4% compared to ¥1,058,578,748.00 in Q3 2019[41] - Net profit for Q3 2020 was ¥208,411,151.93, representing a 75.1% increase from ¥119,047,480.53 in Q3 2019[45] - The company reported a total profit of ¥249,221,836.74 for Q3 2020, up from ¥155,086,142.68 in Q3 2019, marking a growth of 60.6%[45] - The company reported a net profit margin improvement, with retained earnings rising to ¥933,948,529.44 from ¥723,325,607.09, an increase of approximately 29.1%[37] Assets and Liabilities - Total assets reached RMB 6,459,969,710.61, an increase of 39.83% compared to the end of the previous year[9] - The company’s total liabilities increased significantly, with current liabilities totaling RMB 2,980,029,397.63 compared to RMB 2,018,500,511.91 in the previous year[29] - Total liabilities increased to ¥3,532,614,493.65, up from ¥2,215,938,822.91, representing a growth of approximately 59.5% year-over-year[31] - Total equity attributable to shareholders rose to ¥2,808,777,325.33, compared to ¥2,334,071,079.34, marking an increase of about 20.3%[31] - Total assets amounted to ¥4,619,775,351.10, with non-current assets totaling ¥2,011,436,216.00[73] - Current liabilities reached ¥2,018,500,511.91, including short-term borrowings of ¥999,367,115.32 and accounts payable of ¥485,580,224.95[73] - Total liabilities were reported at ¥2,215,938,822.91, with non-current liabilities accounting for ¥197,438,311.00[77] Cash Flow - Net cash flow from operating activities reached RMB 586,194,583.52, a significant increase of 299.82% compared to the previous year[9] - The company reported a net cash outflow from investing activities of RMB -905,539,751.48, primarily due to acquisitions[20] - The net cash flow from investing activities was -¥761,574,918.89, worsening from -¥488,093,684.05 year-over-year[69] - Cash inflow from financing activities reached ¥1,504,360,194.50, up from ¥916,187,250.00 in the same period last year[69] - The net cash flow from financing activities was ¥414,616,683.19, compared to ¥140,026,498.73 in the previous year[69] Shareholder Information - The total number of shareholders at the end of the reporting period was 14,741[14] - The largest shareholder, Ni Zhanggen, holds 53.37% of the shares, amounting to 184,401,319 shares[14] Inventory and Receivables - Accounts receivable increased by 32.03% to RMB 1,044,513,423.09 from RMB 791,096,800.30, primarily due to increased sales volume[18] - Inventory rose by 54.57% to RMB 1,146,600,969.12 from RMB 741,779,717.80, mainly due to the acquisition of the U.S. company MOR's inventory[18] - Accounts receivable increased to ¥1,059,812,236.25 from ¥995,008,019.94, reflecting a growth of about 6.5%[35] - Inventory decreased to ¥247,793,679.07 from ¥271,972,374.42, a reduction of approximately 8.9%[35] Expenses - Sales expenses rose by 139.85% to RMB 842,949,377.88 from RMB 351,452,032.45, reflecting increased sales revenue and expanded sales channels[18] - Research and development expenses for Q3 2020 amounted to ¥37,628,611.83, an increase of 30.8% from ¥28,756,611.01 in Q3 2019[41] - Financial expenses for Q3 2020 were ¥58,453,974.96, a significant increase from a negative expense of -¥3,882,980.24 in Q3 2019[56] - Sales expenses rose to ¥54,348,666.43 in Q3 2020, compared to ¥40,023,552.07 in Q3 2019, indicating increased marketing efforts[52] Strategic Focus - The company aims to enhance market expansion and product development in the upcoming quarters[54]